ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $469,013 | -54.6% | 15,845 | -65.8% | 0.00% | -50.0% |
| Q2 2022 | $1,034,000 | +154.7% | 46,343 | +386.0% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | -25.6% | 9,536 | -28.7% | 0.00% | -33.3% |
| Q1 2021 | $546,000 | +205.0% | 13,383 | +116.7% | 0.00% | +50.0% |
| Q1 2020 | $179,000 | -79.1% | 6,177 | -70.6% | 0.00% | -71.4% |
| Q2 2019 | $855,000 | -74.8% | 21,040 | -81.2% | 0.01% | -56.2% |
| Q1 2019 | $3,388,000 | -25.0% | 112,020 | -16.6% | 0.02% | -65.2% |
| Q4 2018 | $4,515,000 | +429.3% | 134,333 | +604.0% | 0.05% | +475.0% |
| Q1 2016 | $853,000 | +47.6% | 19,081 | +26.0% | 0.01% | +60.0% |
| Q4 2015 | $578,000 | +85.9% | 15,141 | +60.9% | 0.01% | +25.0% |
| Q2 2015 | $311,000 | -84.2% | 9,413 | -80.5% | 0.00% | -84.6% |
| Q4 2014 | $1,967,000 | -26.6% | 48,281 | -34.0% | 0.03% | -33.3% |
| Q3 2014 | $2,681,000 | – | 73,133 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |